125I Seeds Implantation As Brachytherapy in Nude Mice Bearing Human Breast Cancer
CUI Xue-jun,LIU Zeng-li,ZHANG Zhi-yong,SHI Yi-zhen,TANG Jun,YANG Yi
DOI: https://doi.org/10.3969/j.issn.1673-713x.2007.06.007
2007-01-01
Abstract:Objective To assess the efficacy of 125I seeds implantation for human breast cancer in nude mice, and therefore to provide an experimental foundation for clinical trials. Methods Human breast cancer cells MCF-7 were subcutaneously injected into the fat pad of the right breast of 18 Nc-nu/nu nude mice (female, aged 3-4 weeks) to establish human breast cancer models. The mice were divided into treatment group and control group (nine in each). In the treatment group, a 125I seed (29.6 MBq) was implanted into center of the breast tumor. After the injection, the volume of the tumor was recorded daily for 21 days, and the rate of tumor growth inhibition was calculated. On day 21, theperipheral WBC count was determined and then the mice were killed. The tumor, liver, heart, and the right kidney tissues were obtained from the mice, and examined histologically. The tumor tissues were immunohistochemically stained to detect the expressions of PCNA and Bcl-2. And the ultrastructure of the tumor was observed under a transmission electron microscope. Results After the injection of MCF-7 cells, the mean volume of the tumor was (118 ± 14) mm3, while on day 21, it was (21 ± 3) mm3 in the treatment group (t = 20.32, P = 0.00) and (339 ± 32) mm3 in the control (t = 18.98, P = 0.00). Compared with the control, the rate of tumor growth inhibition was 93.8% ± 17.8% in the mice implanted with 125I seeds. No significant difference was detected in the WBC count between the two groups. Light microscopy detected no evidences of radiation injury, including tissue edema and congestion, in the liver, heart, and right kidney. In the tumor tissues, fibrous hyperplasia was observed surrounding the implantation site, and necrotic tissues was found in the center of the tumor. The positive expression rates of PCNA and Bcl-2 were 35.42% ± 3.91% and 11.90% ± 0.75% in the treatment group, which was significantly lower than those in the control (73.39% ± 3.55% and 20.09% ± 1.69%; t = 21.55, P = 0.00 and t = 13.26, P = 0.00, respectively). Transmission electron microscopy showed apoptotic cells, collagenous fiber hyperplasia, and apoptotic bodies in the tumor tissues. Conclusions 125I seeds implantation can significantly inhibit the growth of human breast cancer in nude mice. The results provide a possibility of 125I seeds implantation as a breast-conserving therapy for patients with breast cancer.